Earnings

Aytu Bioscience Inc AYTU Stock News

Aytu BioSceince, on Thursday, reported earnings generated during the first fiscal quarter of 2018. The results highlight significant operational growth for several company brands, inclusive of Natesto®, MiOXSYS®, and Fiera®.





AYTU Trends Are Strong

The quarterly results posted increasing revenue contribution from several pipeline products, proving that the company’s revenue mix is diversifying itself well to position the company for long-term sustainable growth. Highlights from the quarter include:




  • a 54% increase in total revenue in comparison to Q1 2017. AYTU reported $1.1 million in total revenue for the quarter, primarily generated through the surging trends for Natesto®, MiOXSYS®, and Fiera®
  • a 411% surge in Natesto® prescription demand compared to Q1 2017, supported by record high total prescription levels of 2,036 units sold
  • an increase in Natesto® factory sales orders that surpassed 7,000 units, also an all-time high for the product. The results are an 85% increase over the prior comparable quarter
  • an increase in Natesto® prescribers across the United States to 991, a 21% increase over the previous quarter
  • the listing of company shares on the NASDAQ Capital Markets, a move that is expected to generate increased opportunity to attract institutional coverage, partnership opportunity, and stronger financing options if and when needed
  • an increase in the number of MiOXSYS® System placements to 96 on a global basis since Q1 of fiscal 2017. AYTU placed 29 of the instruments in six countries through the Company’s distribution partners.
  • began the commercial integration of Fiera®, AYTU’s women’s sexual wellness product line, highlighted by the launch of the Company’s first international distribution agreement in Japan

Strong Diversified Sales Contribute To Surge In Growth

Strengthened by the more than $1 million in total first quarter revenue, AYTU saw stronger contribution from three pipeline products, Natesto®, MiOXSYS®, and Fiera®. The 54% increase in sales combined to produce total gross receipts of $2.2 million over the same period last year and represents an increase of 142%, respectively.

The completion of AYTU’s recent private placement places the company in stable financial shape, with cash and cash equivalents at the quarter end sitting at roughly $7.1 million on September 30, 2017. In addition to the strengthened balance sheet, AYTU reported a sharp reduction in SG&A expense during the quarter to $4.6 million, representing a 20% decrease from the same quarter last year. The decline in expenses combined with the revenue growth cut the quarterly loss by roughly 26%.

AYTU Positioned For Profitability

Although AYTU did not provide revenue guidance, management indicated that the increase in net revenues contributed from the growth in Natesto®, MiOXSYS®, and Fiera® products place the company within sight of cash-flow breakeven or potential profitability during the middle of fiscal 2019.

The company’s shares responded sharply higher in after-hours trading by more than 11% on the report.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Intercept Pharmaceuticals Inc ICPT Stock News

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is having an incredibly strong start in the pre-market hours this morning, and for good reason. The company reported its earnings for the third quarter, beating expectations and causing excitement among investors. Of course, our partners at Trade Ideas were the first to alert us to the gains. Today, we’ll talk about what we saw from earnings, how the stock reacted to the news and what we’ll be watching ahead with regard to ICPT.





ICPT Gains On Strong Earnings

As mentioned above, Intercept Pharmaceuticals is having a relatively strong start to the trading session in the pre-market hours this morning after the company reported positive financial results for the third quarter. Here’s what we saw from the report:




  • Earnings Per Share – In terms of earnings per share, ICPT did overwhelmingly well. During the quarter, analysts expected that the company would generate a loss per share in the amount of $3.55. However, the company actually reported a loss of $2.89 per share, beating expectations in a big way.
  • Revenue – Revenue also proved to be a big hit. During the third quarter, it was expected that ICPT would generate revenue in the amount of $35.9 million. However, the company actually reported revenue in the amount of $41.3 million, once again, blowing away expectations.

In a statement, Mark Pruzanski, M.D., President and CEO at Intercept Pharmaceuticals, had the following to offer:

We are pleased with our solid commercial performance, with continued quarter over quarter growth underscoring Ocaliva’s importance as a new treatment option in PBC… We have continued to build our leadership position in NASH and are planning to initiate our Phase 3 cirrhosis trial by the end of this year… The interim analysis in our flagship Phase 3 REGENERATE trial is on track to report in the first half of 2019, and is intended to support the filing of a supplemental new drug application for accelerated approval of OCA in NASH patients with fibrosis. We also recently presented positive results of our Phase 2 AESOP trial in primary sclerosing cholangitis at The Liver Meeting hosted by AASLD, establishing proof-of-concept in another progressive, cholestatic liver disease with high unmet need.”

How The Market Reacted To The News

As we’ve come to expect an time a publicly traded company reports strong earnings, ICPT is having an incredible time in the market as a result. While we are still in the pre-market hours, the stock has seen dramatic gains as investor excitement takes hold. At the moment (8:37), the stock is trading at $64.65 per share after a gain of $3.02 per share or 4.90% thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on ICPT. In particular, we’re interested in watching ongoing sales growth as well as the progress with regard to the company’s robust pipeline. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Mondelez International Inc MDLZ Stock News

Mondelez International Inc (NASDAQ: MDLZ) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company reported earnings, not only beating expectations, but proving exponential growth on a year over year basis. Of course, this led to excitement, sending the stock screaming toward the top and prompting our friends at Trade Ideas to send the alert. Below, we’ll talk about what we saw from earnings, how MDLZ reacted to the news, and what we’ll be watching for ahead.





MDLZ Reports Earnings

As mentioned above, Mondelez International is having an overwhelmingly strong start to the trading session this morning after reporting its earnings for the third quarter. Here’s what we saw from the report:




  • Profit – In terms of profit, MDLZ did overwhelmingly well. During the third quarter, the company generated profit in the amount of $992 million or $0.65 per share. That’s a massive increase on a year over year basis from $548 million in profit or $0.35 per share.
  • Earnings Per Share – With the exclusion of one-time gains and costs, MDLZ reported incredibly strong earnings per share. During the quarter, analysts expected that the company would report adjusted earnings per share in the amount of $0.54. However, the company actually reported earnings in the amount of $0.57 per share.
  • Revenue – Finally, revenue also proved to be a big hit for Mondelez International. During the quarter, analysts expected that the company would generate revenue in the amount of $6.46 billion. However, the company actually reported revenue in the amount of $6.53 billion, once again topping expectations.

In a statement, Irene Rosenfeld, CEO at MDLZ, had the following to offer:

We’re making good progress on many of our key strategic initiatives and remain confident in our ability to deliver long-term, sustainable growth on both the top and bottom lines.”

How The Stock Reacted To The News

As we’ve come to expect, any time we see positive earnings results, we can expect to see gains in the value of the stock associated with the earnings. That’s exactly what we’re seeing out of MDLZ today. Currently (9:57), the stock is trading at $41.90 per share after a gain of $2.60 per share or 6.62% thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on MDLZ. In particular, we’re interested in following the ongoing growth as the company saw some compelling movement in the third quarter. It is expected that this momentum will continue through Q4. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 748
DSW, Inc. DSW Stock News

DSW Inc. (NYSE: DSW) is having an overwhelmingly strong start to the day in the pre-market hours this morning, and for good reason. The company released its earnings report for the second quarter, blowing away expectations. On top of that the company also announced a share repurchase program that seems to be yet another source of excitement. As is normally the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (9:28), DSW is trading at $18.70 per share after a gain of $3.01 per share or 19.18% thus far today.





DSW Gains On Strong Earnings

As mentioned above, DSW is having an incredible morning this morning after releasing its earnings report for the second quarter. Here’s what we saw from the report…




  • Earnings Per Share – In terms of earnings per share, DSW did overwhelmingly well. During the quarter, analysts expected that the company would generate earnings in the amount of $0.29 per share. However, the company actually reported earnings in the amount of $0.38 per share, $0.09 ahead of expectations.

  • Revenue – Revenue also proved to be overwhelmingly strong. During the quarter, analysts expected that the company would generate revenue in the amount of $666.66 million. However, the company actually generated revenue in the amount of $680.4 million.

  • Guidance – DSW also informed its investors that guidance was on track. During FY18, the company is expecting to see earnings per share come in the range between $1.45 per share and $1.55 per share. This is overwhelmingly positive considering that analysts currently expect that the company will report full year EPS at $1.44 per share.

  • Share Repurchase Program – Finally, DSW announced that its Board of Directors has approved a new share repurchase program, authorizing the repurchase of $500 million in common stock. This is in addition to the current authorization to repurchase a remaining $33 million. This is big news. In fact, since 2013, the company has sent around $600 million to investors in dividends and share repurchases.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on DSW. In particular, we’re interested in following the company to see if they do indeed reach the high bar they’ve set for themselves for the year 2018. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 1867
ING Group NV ADR ING Stock News

ING Group NV (ADR) (NYSE: ING)

ING Group is having an incredibly rough time in the pre-market trading hours, and for good reason. The company disclosed a criminal probe into their activities. Shortly after the disclosure, our partners at Trade Ideas alerted us to the declines. Currently (8:33), ING is trading at $14.79 per share after a loss of $0.68 per share or 4.40% thus far today.




What We’ll Be Watching For Ahead

CNA Finance will be watching ING Group incredibly closely moving forward. At the moment, there are no details as to why the criminal probe is taking place. However, there are rumors of substantial repercussions to come. Nonetheless, we’ll continue to watch the story closely and bring the news to you as it breaks!

What Do You Think?

Where do you think ING is headed moving forward? Join the discussion in the comments below!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required











[Image Courtesy of Wikimedia]

Novavax NVAX Stock News

Novavax, Inc. (NASDAQ: NVAX)

Novavax is having a rough day in the market today, and for good reason. The company reported its earnings for the first quarter, missing expectations and causing concerns among investors. Today, we’ll talk about what we saw from earnings, how the market is reacting to the news, and what we can expect to see from NVAX moving forward. So, let’s get right to it…

Trade smarter and make more money with Tradespoon!

NVAX Reports Earnings

As mentioned above, Novavax reported its earnings for the first quarter after the closing bell yesterday. Unfortunately, the company missed expectations, leading to declines in the value of the stock. Here’s what we saw from the earnings report:

  • Earnings – In terms of earnings per share, NVAX left much to be desired. During the first quarter, analysts expected that the company would generate a loss of $0.27 per share. However, the company actually reported a loss that was $0.02 per share worse than expected, coming in at $0.29 per share.
  • Revenue – While earnings missed expectations, the big story here was revenue. During the first quarter, analysts expected that NVAX would generate revenue in the amount of $10.39 million. However, the company announced that its revenue came in at less than half of what analysts were expecting to see. In the quarter, the company generated total revenue in the amount of $4.2 million.

How The Market Reacted To The News

As investors, we know that the news moves the market. Any time there is positive news released with regard to a publicly-traded company, we can expect to see gains in the value of the stock associated with that company. On the other hand, when negative news is produced, we can expect to see declines. Unfortunately, the news surrounding Novavax definitely wasn’t positive. Not only did the company slightly miss earnings projections, revenue came in far below what analysts were expecting to see. As a result, we’re seeing declines on the stock during today’s trading session. Currently (10:50), NVAX is trading at $4.61 per share after a loss of $0.17 per share or 3.56% thus far today.

What We Can Expect To See Moving Forward

Moving forward, I have a relatively mixed opinion of what we can expect to see from NVAX. In the short term, we’re likely to see more declines as disappointing quarterly results continue to be a cause for concern among investors. However, in the long run, I do believe that the company will likely pull ahead. The reality is that Novavax is working on incredible vaccines that are much needed in the medical industry. While these product candidates are still in the trial phase, they are looking incredibly promising, which I believe is why the declines realized on the stock today haven’t been larger. All in all, things look tough at the moment, but in the long run, I wouldn’t be surprised to see this stock soar.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think NVAX is headed moving forward? Let us know your opinion in the comments below!

[Image Courtesy of Wikipedia]

Facebook FB Stock News

Facebook Inc (NASDAQ: FB)

Facebook is having an incredible day in the market today. In fact, after reporting earnings for the first quarter, the company’s stock price has jumped into record territory. Today, we’ll talk about what we saw from earnings, how the market reacted to the news, and what we can expect to see from FB stock moving forward. So, let’s get right to it…

Trade smarter and make more money with Tradespoon!

FB Reports Strong Earnings

As mentioned above, Facebook recently reported its earnings for the most recent quarter with such strong results that the value of the stock has jumped into record territory. Here’s what we saw from the earnings report:

  • Revenue – In terms of revenue, FB produced overwhelmingly positive numbers. During the quarter, analysts expected that the company would generate revenue in the amount of $5.26 billion. However, the company actually generated revenue more than $100 million ahead of expectations, coming in at $5.38 billion.
  • Earnings – As if strong revenue wasn’t enough, FB absolutely blew away analyst expectations with regard to earnings. During the first quarter, analysts expected that the company would generate earnings in the amount of $0.62 per share. However, the company actually reported earnings in the amount of $0.77 per share.
  • Active Users – When it comes to monthly active users, Facebook saw incredible growth as well. During the quarter, the social network enjoyed a total of 1.65 million active users. That number is up 15% year-over-year. Not to mention, mobile active users climbed 21% year-over-year to 1.51 billion.

Finally, following the strong earnings, FB announced that it would be proposing the offering of a new class of stock. Here’s what the company had to say:

If the proposal is approved, we intend to issue two shares of Class C capital stock as a one-time stock dividend in respect of each outstanding share of our Class A and Class B common stock.”

How The Market Reacted To The News

As investors, we know that positive news will likely lead to growth in the value of the stock the news is associated with. Obviously, the news released by FB was overwhelmingly positive. This is leading to incredibly strong gains on the stock. In fact, investors have pushed Facebook into record territory. Currently (9:41), FB stock is trading at $120.02 per share after a gain of $11.14 per share or 10.22% thus far today.

What We Can Expect From FB Moving Forward

Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from Facebook. The reality is that the company started as a social network. However, these days, it is a way of life for tons of people. With more than a billion and a half active users, strong plans for future growth, and investments in areas outside the internet, FB is poised for strong long-term growth.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think FB is headed moving forward and why? Let us know your opinion in the comments below!

[Image Courtesy of Wikipedia]

Apple AAPL Stock News

Apple Inc. (NASDAQ: AAPL)

Apple is literally the largest company in the world. However, following the company’s earnings release, it looks like the door is opening for another company to ease into its place. Unfortunately, the tech giant missed the mark with regard to earnings and revenue, upsetting investors and leading to declines that would shed $40 billion + off of its stock price. Today, we’ll talk about what we saw from earnings, how investors reacted to the news, and what we can expect to see from AAPL moving forward. So, let’s get right to it…

Trade smarter and make more money with Tradespoon!

AAPL Earnings Disappoint

As mentioned above, Apple reported earnings for the first quarter yesterday after the closing bell. Unfortunately, the results disappointed investors. Here’s what we saw:

  • Revenue – In terms of revenue, AAPL missed the mark. While analysts were expecting that the company would generate $51.97 billion in revenue for the fist quarter, the company actually reported revenue with a total of $50.56 billion, missing the mark by over a billion dollars!
  • Earnings – Unfortunately, earnings per share wasn’t much better. In the quarter, analysts expected that AAPL would generate earnings in the amount of $2.00 per share. However, the company actually reported earnings $0.10 lower than expectations at $1.90 per share.
  • iPhone Sales – As if low earnings and low revenue weren’t enough to scare investors, Apple released information with regard to iPhone sales that caused quite a bit of concern. In fact, the first quarter of 2016 was the first quarter that the company ever produced a year-over-year sales decline in the iPhone. While Tim Cook believes that the company is still in “the early innings of the iPhone”, investors are taking this as a signal that the company’s tremendous smartphone market share is likely to start declining.

Following the release of earnings, Drexel analyst Brian White made it clear that he isn’t expecting to see much more positivity out of iPhone sales. Here’s what he had to say:

As the iPhone 6-Series nears the end of this two-year cycle and the macro backdrop remains challenging, volatility in Apple’s results is to be expected…”

How The Market Reacted To The News

As investors, one of the first things we learn is that the news moves the market. Any time we see positive news surrounding a publicly traded company, we can expect to see gains in the value of the stock associated with that company as a result. Adversely, when negative news hits, we can expect to see declines. In this particular case, the news was overwhelmingly bad. Not only did AAPL miss the mark with regard to earnings and revenue, the company recorded its first year-over-year decline in iPhone sales. As a result, we’re seeing declines. Currently (10:00), AAPL stock is trading at $96.64 per share after a loss of $7.71 per share or 7.39% thus far today. This equates to a loss of more than $40 billion in the company’s value!

What We Can Expect To See Moving Forward

Moving forward, I have a relatively mixed opinion of what we can expect to see from Apple. In the short term, I am expecting that economic conditions will continue to drive sales down. At the moment, we can expect further declines as investors show their disappointment with the results released. However, in the long run, I have faith that AAPL will be able to get over this hurdle. After all, it didn’t grow to be the largest company in the world without hurdles, and it knows how to make it past rough situations.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think AAPL is headed moving forward and why? Let us know your opinion in the comments below!

[Image Courtesy of Wikipedia]

Cree CREE Stock News

Cree, Inc. (NASDAQ: CREE)

Cree had a rough day in the market yesterday, and it seems as though the volatility is continuing through today. The declines happened for good reason. The reality is that investors are ultimately investing for growth. So, earnings is a big key. Unfortunately, the company announced yesterday that earnings for the third fiscal quarter weren’t likely to hit their mark. Today, we’ll talk about what the company is expecting to see, how the market reacted to the news and what we can expect to see from CREE moving forward. So, let’s get right to it…

Trade smarter and make more money with Tradespoon!

CREE Earnings Are Expected To Miss The Mark

Yesterday, Cree made a key announcement that struck fear into the minds of investors. The company is expecting to miss the mark when it comes to both revenue and earnings on their third quarter earnings release. For the quarter, the company is now expecting to report revenue in the amount of $367 million. In terms of earnings, the company is expecting to produce between a loss of $0.01 and a gain of $0.01 per diluted share on a GAAP basis and between $0.13 and $0.15 on a non-GAAP basis. Of course, these numbers are not set in stone. The figures mentioned above are subject to completion of Cree’s customary quarterly closing and review procedures. Regardless, the company is missing the mark in a big way. The reality is analysts were expecting to see revenue in the amount of $414 million with earnings per share coming in at $0.24. In a statement, Chuck Swoboda, Chairman and CEO at CREE had the following to say about the preliminary data:

The estimated revenue is below the Company’s previously targeted range of $400 million to $430 million due to lower lighting products revenue… I believe we’ve addressed the root causes that led to our recent business challenges. While it’s premature to provide specific targets at this time, the order rate in commercial lighting improved in March, and we’re optimistic that this, combined with demand for new products, will begin to drive growth in fiscal Q4.”

How The Market Reacted To The News

As investors, we know that the news moves the market. Any time there is positive news released with regard to a publicly-traded company, we can expect to see gains in the value of that company. Adversely, when negative news is reported with regard to a publicly-traded company, we can expect to see declines. Of course, announcing the probability of missing earnings and revenue expectations is overwhelmingly negative news. So naturally, we’re seeing declines in the value of the stock. Yesterday, CREE fell in a big way, and the declines are continuing in the market today. Currently (10:20), CREE is trading at $24.48 per share after a loss of $4.57 per share or 15.73% thus far today.

What We Can Expect To See Moving Forward

Moving forward, I have a relatively mixed expectation of what we can expect to see from Cree. In the short term, we are likely to see more declines on the stock as investor concerns with regard to growth continue to take control over the movement. However, in the long run, I’m expecting positivity. The CEO announced that they have found the root cause of the decline in sales, and perhaps more importantly, the numbers were up in March. With that said, I’m expecting the situation with regard to sales to improve, which will lead to gains in the value of the stock in the long run. So, watch for the bottom of the dip, it may be a good time to get involved.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think CREE is headed and why? Let us know your opinion in the comments below.

[Image Courtesy of Vimeo]

Oracle Corporation ORCL Stock News

Oracle Corporation (NYSE: ORCL)

Oracle Corporation is having an incredibly strong day in the market today, and for good reason. The company reported earnings yesterday after the closing bell, blowing away expectations and exciting investors. Today, we’ll take a look at what we saw from earnings, how the market reacted to the news, and what we can expect to see from ORCL moving forward. So, let’s get right to it…

Trade smarter and make more money with Tradespoon!

Oracle Produces Solid Earnings

As mentioned above, ORCL reported its earnings for Q3 after the closing bell yesterday as expected. However the company surprised investors, not only by blowing away earnings estimates, but also by declaring a dividend and announcing the repurchase of common stock. Here’s what we saw:

  • Earnings Per Share – In terms of earnings per share, it was expected that ORCL would generated $0.62 in the quarter. However, the company actually generated earnings in the amount of $0.64 per share, beating analyst expectations by $0.02 per share.
  • Revenue – When it comes to revenue, ORCL produced a slight miss. In the quarter, analysts expected for the company to generate revenue in the amount of $9.12 billion. However, Oracle was able to generate $9 billion even in the quarter.
  • Declaration Of Cash Dividend – On top of the strong earnings, the company also made a big declaration today. ORCL will start paying dividends in the amount of $0.15 per share. The dividend will be paid to stockholders on record as of the close of business on April 14th and will be paid to stockholders on April 28th, 2016.
  • Stock Repurchasing – Finally, ORCL showed its strength and confidence in long-term growth by announcing that the Board of Directors has authorized a large common stock repurchase plan. The company will be repurchasing up to an additional $10 billion of common stock under its existing share repurchase program in quarters to come.

How The Market Reacted To The News

As investors, we know that the news moves the market. Ultimately, there are few pieces of news that have the ability to move the market like strong earnings, dividends, and stock repurchases. ORCL happened to release all three of these at once. So, it only makes sense that we’re seeing big gains on Oracle’s stock today. Currently (11:07), the stock is trading at $40.41 per share after a gain of $1.67 per share or 4.31% thus far today.

What We Can Expect To See Moving Forward

Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from Oracle. The company, which is focused on online software, has an incredible line of products for which demand is very high. Proof of this can be seen by simply taking a look at the ORCL earnings report. Having great products is one thing, but having the ability to market those products is another. However, ORCL has an incredible team, both in management and as employees. All in all, everything is pointing to strong, long-term growth from ORCL.

Don’t waste your time! Click here to find winning trades in minutes!

What Do You Think?

Where do you think ORCL is headed moving forward and why? Let us know your opinion in the comments below!

[Image Courtesy of Wikimedia]

Thought Leader Discussions

Gevo, Inc. GEVO Stock News

0 7197
Gevo, Inc. (NASDAQ: GEVO) Before we get into this interview, I'd like to extend a special thanks to my friend Joey who both set up the...